5 ways biotech startups can mitigate risk to grow sustainably in the long run
TechCrunch
OCTOBER 28, 2022
The infrastructure needed to maintain these different programs can be too unwieldy to weather a financial drought. A better approach would be to focus on a lead program — a single product that they can take through various stages of development, ultimately leading to FDA approval.
Let's personalize your content